Immune response pattern in recurrent Plasmodium vivax malaria
Authors:
- Yury Oliveira ChavesYCYury Oliveira Chaves
- Allyson Guimarães da CostaACAllyson Guimarães da Costa
- Marcelo Luís Monteiro PereiraMPMarcelo Luís Monteiro Pereira
- Marcus Vinícius Guimarães de LacerdaMLMarcus Vinícius Guimarães de Lacerda
- Jordana Grazziela Coelho-Dos-ReisJCJordana Grazziela Coelho-Dos-Reis
- Olindo Assis Martins-FilhoOMOlindo Assis Martins-Filho
- Andréa Teixeira-CarvalhoATAndréa Teixeira-Carvalho
- Adriana MalheiroAMAdriana Malheiro
- Wuelton Marcelo MonteiroWuelton Marcelo Monteiro
- Patrícia Puccinelli OrlandiPOPatrícia Puccinelli Orlandi
- Claudio Romero Farias MarinhoClaudio Romero Farias Marinho
- Paulo Afonso NogueiraPNPaulo Afonso Nogueira
Open Access
- 31 August 2016
- journal article
- research article
- Published by Springer Nature in Malaria Journal
- Vol. 15 (1) , 1-13
Abstract
Plasmodium vivax is the causative agent of human malaria of large geographic distribution, with 35 million cases annually. In Brazil, it is the most prevalent species, being responsible by around 70 % of the malaria cases. A cross-sectional study was performed in Manaus (Amazonas, Brazil), including 36 adult patients with primary malaria, 19 with recurrent malaria, and 20 endemic controls. The ex vivo phenotypic features of circulating leukocyte subsets (CD4+ T-cells, CD8+ T-cells, NK, NKT, B, B1 and Treg cells) as well as the plasmatic cytokine profile (IL-2, IL-4, IL-6, IL-10, TNF and IFN-γ) were assessed, aiming at establishing patterns of immune response characteristic of primary malaria vs recurrent malaria as compared to endemic controls. The proportion of subjects with high levels of WBC was reduced in malaria patients as compared to the endemic control. Monocytes were diminished particularly in patients with primary malaria. The proportion of subjects with high levels of all lymphocyte subsets was decreased in all malaria groups, regardless their clinical status. Decreased proportion of subjects with high levels of CD4+ and CD8+ T-cells was found especially in the group of patients with recurrent malaria. Data analysis indicated significant increase in the proportion of the subjects with high plasmatic cytokine levels in both malaria groups, characterizing a typical cytokine storm. Recurrent malaria patients displayed the highest plasmatic IL-10 levels, that correlated directly with the CD4+/CD8+ T-cells ratio and the number of malaria episodes. The findings confirm that the infection by the P. vivax causes a decrease in peripheral blood lymphocyte subsets, which is intensified in the cases of “recurrent malaria”. The unbalanced CD4+/CD8+ T-cells ratio, as well as increased IL-10 levels were correlated with the number of recurrent malaria episodes. These results suggest that the gradual remodelling of the immune response is dependent on the repeated exposure to the parasite, which involves a strict control of the immune response mediated by the CD4+/CD8+ T-cell unbalance and exacerbated IL-10 secretion.Keywords
Funding Information
- FIOCRUZ-FAPEAM (759/2014)
- INCT-Vacinas/CNPq (573547/2008-4)
This publication has 88 references indexed in Scilit:
- Plasmodium vivax associated severe malaria complications among children in some malaria endemic areas of EthiopiaBMC Public Health, 2013
- Thrombocytopenia in Plasmodium vivax Malaria Is Related to Platelets PhagocytosisPLOS ONE, 2013
- Determinants of relapse periodicity in Plasmodium vivax malariaMalaria Journal, 2011
- Increased interleukin-10 and interferon-γ levels in Plasmodium vivax malaria suggest a reciprocal regulation which is not altered by IL-10 gene promoter polymorphismMalaria Journal, 2011
- Bacteremia in Kenyan Children Presenting with MalariaJournal of Clinical Microbiology, 2011
- Immune response toPlasmodium vivaxhas a potential to reduce malaria severityClinical and Experimental Immunology, 2009
- Resistance to Therapies for Infection byPlasmodium vivaxClinical Microbiology Reviews, 2009
- CD4+CD25+Regulatory T Cells Suppress CD4+T-Cell Function and Inhibit the Development ofPlasmodium berghei-Specific TH1 Responses Involved in Cerebral Malaria PathogenesisInfection and Immunity, 2007
- Dihydroartemisinin-Piperaquine versus Artesunate-Amodiaquine: Superior Efficacy and Posttreatment Prophylaxis against Multidrug-Resistant Plasmodium falciparum and Plasmodium vivax MalariaClinical Infectious Diseases, 2007
- Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparisonThe Lancet, 2007